MyFinsight
Home
About
Contact
vnda: the income statement
Download
Download image
Net loss
-$22,586K
(-324.23%↓ Y/Y)
Benefit for income taxes
-$5,804K
(-530.87%↓ Y/Y)
PONVORY
$7,035K
Hetlioz
$17,978K
Fanapt
$31,245K
Loss before income
taxes
-$28,390K
(-354.68%↓ Y/Y)
Other income, net
$2,894K
(-39.15%↓ Y/Y)
Net product sales
$56,258K
Loss from operations
-$31,284K
(-184.40%↓ Y/Y)
Total revenues
$56,258K
(18.06%↑ Y/Y)
Total operating
expenses
$87,542K
(49.26%↑ Y/Y)
Intangible asset
amortization
$1,752K
(0.06%↑ Y/Y)
Selling, general and
administrative
$60,273K
(60.42%↑ Y/Y)
Research and development
$22,563K
(34.50%↑ Y/Y)
Cost of goods sold
excluding amortization
$2,954K
(15.80%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (VNDA)